| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1306-1320, Copyright © 1995 by Endocrine Society
ARTICLES |
T Jin and DJ Drucker
Department of Medicine, Banting and Best Diabetes Centre, Toronto Hospital, University of Toronto, Ontario, Canada.
The gene encoding proglucagon is restricted in expression to the central nervous system, endocrine pancreas, and intestine. Transgenic experiments indicate that the proglucagon gene upstream enhancer (GUE) element is a principal determinant of both the tissue specificity and the relative level of proglucagon gene transcription. We have now sequenced the rat proglucagon GUE and analyzed the transcriptional properties of proglucagon-luciferase fusion genes (that contain 5'- and 3'-deletions in the GUE) after transfection of islet (InR1-G9) and enteroendocrine (STC-1 and GLUTag) cell lines. The GUE contains both positive and negative elements that are recognized differentially in islet vs. intestinal cell lines. The transcriptional properties of the GUE sequences were more similar in cell lines of intestinal (STC-1 and GLUTag) compared with islet (InR1-G9) phenotypes. The electrophoretic mobility shift assay was used to identify specific domains of the GUE that interacted with nuclear proteins from islet and intestinal cells. Several GUE sequences recognized proteins present in both fibroblast and endocrine cell lines. In contrast, electrophoretic mobility shift assay experiments also identified 1) GUE-protein complexes common to both islet and intestinal cell lines and 2) GUE-protein complexes specific to either islet or intestinal lineages. One of the GUE subdomains, designated GLUE1, displayed enhancer-like activity in InR1- G9 and GLUTag, but not BHK, cell lines. Taken together, these observations demonstrate that the proglucagon GUE is comprised of multiple positive and negative domains that likely function in a combinatorial fashion to regulate islet and intestinal-specific proglucagon gene transcription.
This article has been cited by other articles:
 |
|
 |
|
  D. Islam, N. Zhang, P. Wang, H. Li, P. L. Brubaker, H. Y. Gaisano, Q. Wang, and T. Jin Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic {alpha}- and intestinal L-cell lines Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E174 - E181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kim and J. M. Egan The Role of Incretins in Glucose Homeostasis and Diabetes Treatment Pharmacol. Rev., December 1, 2008; 60(4): 470 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jin Mechanisms underlying proglucagon gene expression J. Endocrinol., July 1, 2008; 198(1): 17 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lotfi, Z. Li, J. Sun, Y. Zuo, P. P. L. Lam, Y. Kang, M. Rahimi, D. Islam, P. Wang, H. Y. Gaisano, et al. Role of the Exchange Protein Directly Activated by Cyclic Adenosine 5'-Monophosphate (Epac) Pathway in Regulating Proglucagon Gene Expression in Intestinal Endocrine L Cells Endocrinology, August 1, 2006; 147(8): 3727 - 3736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wang, T. Liu, Z. Li, X. Ma, and T. Jin Redundant and Synergistic Effect of Cdx-2 and Brn-4 on Regulating Proglucagon Gene Expression Endocrinology, April 1, 2006; 147(4): 1950 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhao, T. Liu, N. Zhang, F. Yi, Q. Wang, I. G. Fantus, and T. Jin Role of Cdx-2 in insulin and proglucagon gene expression: a study using the RIN-1056A cell line with an inducible gene expression system J. Endocrinol., July 1, 2005; 186(1): 179 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yi, P. L. Brubaker, and T. Jin TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by {beta}-Catenin and Glycogen Synthase Kinase-3{beta} J. Biol. Chem., January 14, 2005; 280(2): 1457 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Sherwood, S. L. Krueckl, and J. E. McRory The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily Endocr. Rev., December 1, 2000; 21(6): 619 - 670. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Hussain and J. F. Habener Glucagon Gene Transcription Activation Mediated by Synergistic Interactions of pax-6 and cdx-2 with the p300 Co-activator J. Biol. Chem., October 8, 1999; 274(41): 28950 - 28957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nian, D. J. Drucker, and D. Irwin Divergent regulation of human and rat proglucagon gene promoters in vivo Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G829 - G837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hill, S. L. Asa, and D. J. Drucker Essential Requirement for Pax6 in Control of Enteroendocrine Proglucagon Gene Transcription Mol. Endocrinol., September 1, 1999; 13(9): 1474 - 1486. [Abstract] [Full Text]
|
|
|
|
|
|
T. Jin, D. K. Y. Trinh, F. Wang, and D. J. Drucker The Caudal Homeobox Protein cdx-2/3 Activates Endogenous Proglucagon Gene Expression in InR1-G9 Islet Cells Mol. Endocrinol., February 1, 1997; 11(2): 203 - 209. [Abstract] [Full Text]
|
|
|
|
|
|
T. Jin and H. Li POU Homeodomain Protein OCT1 Is Implicated in the Expression of the Caudal-related Homeobox Gene Cdx-2 J. Biol. Chem., April 27, 2001; 276(18): 14752 - 14758. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
